Advertisement

Topics

JHL Biotech gets positive CHMP scientific advice for phase III trial of proposed trastuzumab biosimilar to treat breast cancer

16:12 EDT 11 Aug 2018 | PharmaBiz

JHL Biotech has received a positive Scientific Advice from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) related to the EU approval pathway

Original Article: JHL Biotech gets positive CHMP scientific advice for phase III trial of proposed trastuzumab biosimilar to treat breast cancer

NEXT ARTICLE

More From BioPortfolio on "JHL Biotech gets positive CHMP scientific advice for phase III trial of proposed trastuzumab biosimilar to treat breast cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...